AEG-1/MTDH/LYRIC, the Beginning: Initial cloning, structure, expression profile, and regulation of expression.

Advances in Cancer Research

Volumn 120, Issue , 2013, Pages 1-38

  Lee, Seok Geun ^a   Kang, Dong Chul ^b   DeSalle, Rob ^c,d   Sarkar, Devanand ^e   Fisher, Paul B ^e  

^a Kyung Hee University   (South Korea)

^b Hallym University   (South Korea)

^c DIVISION OF INVERTEBRATE ZOOLOGY   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

AEG 1 MTDH LYRIC; C Myc; Cloning; Ha ras; HIV; PI3K AKT

Indexed keywords

METADHERIN; PROTEIN; PROTEIN AEG 1; PROTEIN LYRIC; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CYTOPLASM; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; HUMAN; INFLAMMATION; NEOPLASM; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOLUS; ONCOGENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

AEG-1/MTDH/LYRIC; C-MYC; CLONING; HA-RAS; HIV; PI3K/AKT;

ANIMALS; BIOMEDICAL RESEARCH; CELL ADHESION MOLECULES; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; HUMANS; MENTAL DISORDERS; NEOPLASMS; PROTEIN CONFORMATION; TRANSCRIPTOME;

EID: 84880927036     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-401676-7.00001-2     Document Type: Chapter

References (110)

1. Anttila V., Stefansson H., Kallela M., Todt U., Terwindt G.M., Calafato M.S., et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nature Genetics 2010, 42(10):869-873.
2. Ash S.C., Yang D.Q., Britt D.E. LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochemical and Biophysical Research Communications 2008, 371(2):333-338.
3. Bhutia S.K., Kegelman T.P., Das S.K., Azab B., Su Z.Z., Lee S.G., et al. Astrocyte elevated gene-1 induces protective autophagy. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(51):22243-22248.
4. Borjabad A., Brooks A.I., Volsky D.J. Gene expression profiles of HIV-1-infected glia and brain: Toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders. Journal of Neuroimmune Pharmacology 2010, 5(1):44-62.
5. Borley J., Wilhelm-Benartzi C., Brown R., Ghaem-Maghami S. Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review. British Journal of Cancer 2012, 107(7):1069-1074.
6. Boukerche H., Su Z.Z., Kang D.C., Fisher P.B. Identification and cloning of genes displaying elevated expression as a consequence of metastatic progression in human melanoma cells by rapid subtraction hybridization. Gene 2004, 343(1):191-201.
7. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999, 13(1):1-22.
8. Britt D.E., Yang D.F., Yang D.Q., Flanagan D., Callanan H., Lim Y.P., et al. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Experimental Cell Research 2004, 300(1):134-148.
9. Brown D.M., Ruoslahti E. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004, 5(4):365-374.
10. Carnemolla A., Fossale E., Agostoni E., Michelazzi S., Calligaris R., De Maso L., et al. Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease. The Journal of Biological Chemistry 2009, 284(27):18167-18173.
11. Chen X., Dong K., Long M., Lin F., Wang X., Wei J., et al. Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors. Oncology Letters 2012, 4(2):319-323.
12. Chen W., Ke Z., Shi H., Yang S., Wang L. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma 2010, 57(6):522-529.
13. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1(8):623-634.
14. Deng N., Feng Y. Expression of EphA7 and MTDH and clinicopathological significance in the squamous cell cancer of the tongue. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2011, 36(12):1195-1198.
15. Duchen M.R. Mitochondria, calcium-dependent neuronal death and neurodegenerative disease. Pflügers Archiv 2012, 464(1):111-121.
16. Emdad L., Lee S.G., Su Z.Z., Jeon H.Y., Boukerche H., Sarkar D., et al. Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(50):21300-21305.
17. Emdad L., Sarkar D., Lee S.G., Su Z.Z., Yoo B.K., Dash R., et al. Astrocyte elevated gene-1: A novel target for human glioma therapy. Molecular Cancer Therapeutics 2010, 9(1):79-88.
18. Emdad L., Sarkar D., Su Z.Z., Lee S.G., Kang D.C., Bruce J.N., et al. Astroeyte elevated gene-1: Recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacology and Therapeutics 2007, 114(2):155-170.
19. Emdad L., Sarkar D., Su Z.Z., Randolph A., Boukerche H., Valerie K., et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis. Cancer Research 2006, 66(3):1509-1516.
20. Ge X., Lv X., Feng L., Liu X., Gao J., Chen N., et al. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma. PLoS One 2012, 7(6):e39449.
21. Gnosa S., Shen Y.M., Wang C.J., Zhang H., Stratmann J., Arbman G., et al. Expression of AEG-1 mRNA and protein in colorectal cancer patients and colon cancer cell lines. Journal of Translational Medicine 2012, 10:109.
22. Gong Z., Liu W., You N., Wang T., Wang X., Lu P., et al. Prognostic significance of metadherin overexpression in hepatitis B virus-related hepatocellular carcinoma. Oncology Reports 2012, 27(6):2073-2079.
23. Gonzalez-Scarano F., Martin-Garcia J. The neuropathogenesis of AIDS. Nature Reviews Immunology 2005, 5(1):69-81.
24. He X.X., Chang Y., Meng F.Y., Wang M.Y., Xie Q.H., Tang F., et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012, 31(28):3357-3369.
25. Hornbeck P.V., Kornhauser J.M., Tkachev S., Zhang B., Skrzypek E., Murray B., et al. PhosphoSitePlus: A comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Research 2012, 40(Database issue):D261-D270.
26. Hu G., Chong R.A., Yang Q., Wei Y., Blanco M.A., Li F., et al. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 2009, 15(1):9-20.
27. Hui A.B., Bruce J.P., Alajez N.M., Shi W., Yue S., Perez-Ordonez B., et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clinical Cancer Research 2011, 17(24):7539-7550.
28. Isozaki Y., Hoshino I., Nohata N., Kinoshita T., Akutsu Y., Hanari N., et al. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. International Journal of Oncology 2012, 41(3):985-994.
29. Jansson M.D., Lund A.H. MicroRNA and cancer. Molecular Oncology 2012, 6(6):590-610.
30. Jeon H.Y., Choi M., Howlett E.L., Vozhilla N., Yoo B.K., Lloyd J.A., et al. Expression patterns of astrocyte elevated gene-1 (AEG-1) during development of the mouse embryo. Gene Expression Patterns 2010, 10(7-8):361-367.
31. Jian-bo X., Hui W., Yu-long H., Chang-hua Z., Long-juan Z., Shi-rong C., et al. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Medical Oncology 2011, 28(2):455-462.
32. Jiang H., Kang D.C., Alexandre D., Fisher P.B. RaSH, a rapid subtraction hybridization approach for identifying and cloning differentially expressed genes. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(23):12684-12689.
33. Jiang T., Zhu A., Zhu Y., Piao D. Clinical implications of AEG-1 in liver metastasis of colorectal cancer. Medical Oncology 2012, 29(4):2858-2863.
34. Kang D.C., Fisher P.B. Complete open reading frame (C-ORF) technology: Simple and efficient technique for cloning full-length protein-coding sequences. Gene 2005, 353(1):1-7.
35. Kang D.C., Fisher P.B. Complete open reading frame (C-ORF) technique: Rapid and efficient method for obtaining complete protein coding sequences. Methods in Molecular Biology 2007, 383:123-133.
36. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., Fisher P.B. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(2):637-642.
37. Kang D.C., Jiang H., Su Z.Z., Volsky D.J., Fisher P.B. RaSH-Rapid subtraction hybridization. Analysig gene expression 2002, 206-214. Wiley-VCH, Germany. S. Lorkowski, P. Cullen (Eds.).
38. Kang D.C., Su Z.Z., Sarkar D., Emdad L., Volsky D.J., Fisher P.B. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005, 353(1):8-15.
39. Ke Z.F., He S., Li S., Luo D., Feng C., Zhou W. Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis. Cancer Epidemiology 2012, 37(2):179-185.
40. Khuda I.I., Koide N., Noman A.S., Dagvadorj J., Tumurkhuu G., Naiki Y., et al. Astrocyte elevated gene-1 (AEG-1) is induced by lipopolysaccharide as toll-like receptor 4 (TLR4) ligand and regulates TLR4 signalling. Immunology 2009, 128(1 Suppl.):e700-e706.
41. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 2007, 26(55):7647-7655.
42. Kim K., Lee S.G., Kegelman T.P., Su Z.Z., Das S.K., Dash R., et al. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. Journal of Cellular Physiology 2011, 226(10):2484-2493.
43. Kornegoor R., Moelans C.B., Verschuur-Maes A.H., Hogenes M.C., de Bruin P.C., Oudejans J.J., et al. Oncogene amplification in male breast cancer: Analysis by multiplex ligation-dependent probe amplification. Breast Cancer Research and Treatment 2012, 135(1):49-58.
44. Lee S.G., Jeon H.Y., Su Z.Z., Richards J.E., Vozhilla N., Sarkar D., et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009, 28(26):2476-2484.
45. Lee H.J., Jung D.B., Sohn E.J., Kim H.H., Park M.N., Lew J.H., et al. Inhibition of hypoxia inducible factor alpha and astrocyte-elevated gene-1 mediates cryptotanshinone exerted antitumor activity in hypoxic PC-3 cells. Evidence-Based Complementary and Alternative Medicine: eCAM 2012, 2012:13. (Research Article).
46. Lee S.G., Kim K., Kegelman T.P., Dash R., Das S.K., Choi J.K., et al. Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity. Cancer Research 2011, 71(20):6514-6523.
47. Lee S.G., Su Z.Z., Emdad L., Gupta P., Sarkar D., Borjabad A., et al. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. The Journal of Biological Chemistry 2008, 283(19):13116-13123.
48. Lee S.G., Su Z.Z., Emdad L., Sarkar D., Fisher P.B. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(46):17390-17395.
49. Leszczyniecka M., Kang D.C., Sarkar D., Su Z.Z., Holmes M., Valerie K., et al. Identification and cloning of human polynucleotide phosphorylase, hPNPase old-35, in the context of terminal differentiation and cellular senescence. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(26):16636-16641.
50. Li J., Chen Y., Zhao J., Kong F., Zhang Y. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Letters 2011, 304(1):52-59.
51. Li C., Li R., Song H., Wang D., Feng T., Yu X., et al. Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer. Journal of Surgical Oncology 2011, 103(2):184-192.
52. Li C., Li Y., Wang X., Wang Z., Cai J., Wang L., et al. Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma. Histopathology 2012, 60(6):953-963.
53. Li C., Liu J., Lu R., Yu G., Wang X., Zhao Y., et al. AEG -1 overexpression: A novel indicator for peritoneal dissemination and lymph node metastasis in epithelial ovarian cancers. International Journal of Gynecological Cancer 2011, 21(4):602-608.
54. Li J., Yang L., Song L., Xiong H., Wang L., Yan X., et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 2009, 28(36):3188-3196.
55. Li J., Zhang N., Song L.B., Liao W.T., Jiang L.L., Gong L.Y., et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clinical Cancer Research 2008, 14(11):3319-3326.
56. Li J., Zhang Y., Zhao J., Kong F., Chen Y. Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells. Molecular and Cellular Biochemistry 2011, 357(1-2):31-38.
57. Liao W.T., Guo L., Zhong Y., Wu Y.H., Li J., Song L.B. Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. Journal of Translational Medicine 2011, 9:205.
58. Ligthart L., de Vries B., Smith A.V., Ikram M.A., Amin N., Hottenga J.J., et al. Meta-analysis of genome-wide association for migraine in six population-based European cohorts. European Journal of Human Genetics 2011, 19(8):901-907.
59. Liu H.Y., Liu C.X., Han B., Zhang X.Y., Sun R.P. AEG-1 is associated with clinical outcome in neuroblastoma patients. Cancer Biomarkers 2011, 11(2):115-121.
60. Liu L., Wu J., Ying Z., Chen B., Han A., Liang Y., et al. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Research 2010, 70(9):3750-3759.
61. Liu D.C., Yang Z.L. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. Diagnostic Cytopathology 2011, 41(3):199-205.
62. Liu X., Zhang N., Li X., Moran M.S., Yuan C., Yan S., et al. Identification of novel variants of metadherin in breast cancer. PLoS One 2011, 6(3):e17582.
63. Luparello C., Longo A., Vetrano M. Exposure to cadmium chloride influences astrocyte-elevated gene-1 (AEG-1) expression in MDA-MB231 human breast cancer cells. Biochimie 2012, 94(1):207-213.
64. Meng F., Luo C., Ma L., Hu Y., Lou G. Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma. International Journal of Gynecological Pathology 2011, 30(2):145-150.
65. Noch E., Bookland M., Khalili K. Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biology & Therapy 2011, 11(1):32-39.
66. Nohata N., Hanazawa T., Kikkawa N., Mutallip M., Sakurai D., Fujimura L., et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). Journal of Human Genetics 2011, 56(8):595-601.
67. Rehman A.O., Wang C.Y. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. International Journal of Oral Science 2009, 1(3):105-118.
68. Ronquist F., Teslenko M., van der Mark P., Ayres D.L., Darling A., Hohna S., et al. MrBayes 3.2: Efficient Bayesian phylogenetic inference and model choice across a large model space. Systems Biology 2012, 61(3):539-542.
69. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433(7021):73-77.
70. Santarpia M., Magri I., Sanchez-Ronco M., Costa C., Molina-Vila M.A., Gimenez-Capitan A., et al. mRNA expression levels and genetic status of genes involved in the EGFR and NF-kappaB pathways in metastatic non-small-cell lung cancer patients. Journal of Translational Medicine 2011, 9:163.
71. Sarkar D., Emdad L., Lee S.G., Yoo B.K., Su Z.Z., Fisher P.B. Astrocyte elevated gene-1: Far more than just a gene regulated in astrocytes. Cancer Research 2009, 69(22):8529-8535.
72. Sarkar D., Park E.S., Emdad L., Lee S.G., Su Z.Z., Fisher P.B. Molecular basis of nuclear factor-kappa B activation by astrocyte elevated gene-1. Cancer Research 2008, 68(5):1478-1484.
73. Simm M., Su Z., Huang E.Y., Chen Y., Jiang H., Volsky D.J., et al. Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH. Gene 2001, 269(1-2):93-101.
74. Song Y.H., Jeong S.J., Kwon H.Y., Kim B., Kim S.H., Yoo D.Y. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells. Biological and Pharmaceutical Bulletin 2012, 35(7):1022-1028.
75. Song H., Li C., Li R., Geng J. Prognostic significance of AEG-1 expression in colorectal carcinoma. International Journal of Colorectal Disease 2010, 25(10):1201-1209.
76. Song H., Li C., Lu R., Zhang Y., Geng J. Expression of astrocyte elevated gene-1: A novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. International Journal of Gynecological Cancer 2010, 20(7):1188-1196.
77. Song L., Li W., Zhang H., Liao W., Dai T., Yu C., et al. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human non-small cell lung cancer. The Journal of Pathology 2009, 219(3):317-326.
78. Su Z.Z., Chen Y., Kang D.C., Chao W., Simm M., Volsky D.J., et al. Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment. Gene 2003, 306:67-78.
79. Su Z.Z., Kang D.C., Chen Y., Pekarskaya O., Chao W., Volsky D.J., et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 2002, 21(22):3592-3602.
80. Su Z.Z., Kang D.C., Chen Y., Pekarskaya O., Chao W., Volsky D.J., et al. Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization. Journal of Neurovirology 2003, 9(3):372-389.
81. Su Z.Z., Leszczyniecka M., Kang D.C., Sarkar D., Chao W., Volsky D.J., et al. Insights into glutamate transport regulation in human astrocytes: Cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). Proceedings of the National Academy of Sciences of the United States of America 2003, 100(4):1955-1960.
82. Su P., Zhang Q., Yang Q. Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue. Diagnostic Pathology 2010, 5:38.
83. Sun W., Fan Y.Z., Xi H., Lu X.S., Ye C., Zhang J.T. Astrocyte elevated gene-1 overexpression in human primary gallbladder carcinomas: An unfavorable and independent prognostic factor. Oncology Reports 2011, 26(5):1133-1142.
84. Sun S., Ke Z., Wang F., Li S., Chen W., Han A., et al. Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human nonsmall cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression. Human Pathology 2012, 43(7):1051-1060.
85. Sutherland H.G., Lam Y.W., Briers S., Lamond A.I., Bickmore W.A. 3D3/lyric: A novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Experimental Cell Research 2004, 294(1):94-105.
86. Thirkettle H.J., Girling J., Warren A.Y., Mills I.G., Sahadevan K., Leung H., et al. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clinical Cancer Research 2009, 15(9):3003-3013.
87. Thirkettle H.J., Mills I.G., Whitaker H.C., Neal D.E. Nuclear LYRIC/AEG-1 interacts with PLZF and relieves PLZF-mediated repression. Oncogene 2009, 28(41):3663-3670.
88. Tokunaga E., Nakashima Y., Yamashita N., Hisamatsu Y., Okada S., Akiyoshi S., et al. Overexpression of metadherin/MTDH is associated with an aggressive phenotype and a poor prognosis in invasive breast cancer. Breast Cancer 2012, 10.1007/s12282-012-0398-2.
89. Vartak-Sharma N., Ghorpade A. Astrocyte elevated gene-1 regulates astrocyte responses to neural injury: Implications for reactive astrogliosis and neurodegeneration. Journal of Neuroinflammation 2012, 9:195.
90. Wang N., Du X., Zang L., Song N., Yang T., Dong R., et al. Prognostic impact of Metadherin-SND1 interaction in colon cancer. Molecular Biology Reports 2012, 39(12):10497-10504.
91. Wang F., Ke Z.F., Sun S.J., Chen W.F., Yang S.C., Li S.H., et al. Oncogenic roles of astrocyte elevated gene-1 (AEG-1) in osteosarcoma progression and prognosis. Cancer Biology & Therapy 2011, 12(6):539-548.
92. Wang Z., Trillo-Pazos G., Kim S.Y., Canki M., Morgello S., Sharer L.R., et al. Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: Potential role in neuropathogenesis. Journal of Neurovirology 2004, 10(Suppl. 1):25-32.
93. Ward A., Balwierz A., Zhang J.D., Kublbeck M., Pawitan Y., Hielscher T., et al. Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene 2012, 32(9):1173-1182.
94. Watkins S., Sontheimer H. Unique biology of gliomas: Challenges and opportunities. Trends in Neurosciences 2012, 35(9):546-556.
95. Xia Y., Dai J., Lu P., Huang Y., Zhu Y., Zhang X. Distinct effect of CD40 and TNF-signaling on the chemokine/chemokine receptor expression and function of the human monocyte-derived dendritic cells. Cellular and Molecular Immunology 2008, 5(2):121-131.
96. Xia Z., Zhang N., Jin H., Yu Z., Xu G., Huang Z. Clinical significance of astrocyte elevated gene-1 expression in human oligodendrogliomas. Clinical Neurology and Neurosurgery 2010, 112(5):413-419.
97. Xue Y., Ren J., Gao X., Jin C., Wen L., Yao X. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Molecular & Cellular Proteomics 2008, 7(9):1598-1608.
98. Yan J., Zhang M., Chen Q., Zhang X. Expression of AEG-1 in human T-cell lymphoma enhances the risk of progression. Oncology Reports 2012, 28(6):2107-2114.
99. Yang Y., Wu J., Guan H., Cai J., Fang L., Li J., et al. MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. FEBS Letters 2012, 586(20):3608-3612.
100. Ying Z., Li J., Li M. Astrocyte elevated gene 1: Biological functions and molecular mechanism in cancer and beyond. Cell and Bioscience 2011, 1(1):36.
101. Yoo B.K., Emdad L., Lee S.G., Su Z.Z., Santhekadur P., Chen D., et al. Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology. Pharmacology and Therapeutics 2011, 130(1):1-8.
102. Yoo B.K., Emdad L., Su Z.Z., Villanueva A., Chiang D.Y., Mukhopadhyay N.D., et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. The Journal of Clinical Investigation 2009, 119(3):465-477.
103. Yoo B.K., Santhekadur P.K., Gredler R., Chen D., Emdad L., Bhutia S., et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 2011, 53(5):1538-1548.
104. Yu C., Chen K., Zheng H., Guo X., Jia W., Li M., et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009, 30(5):894-901.
105. Zhang B., Liu X.X., He J.R., Zhou C.X., Guo M., He M., et al. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis 2011, 32(1):2-9.
106. Zhang F., Yang Q., Meng F., Shi H., Li H., Liang Y., et al. Astrocyte elevated gene-1 interacts with beta-catenin and increases migration and invasion of colorectal carcinoma. Molecular Carcinogenesis 2012, 10.1002/mc.21894.
107. Zhao Y., Kong X., Li X., Yan S., Yuan C., Hu W., et al. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One 2011, 6(12):e29363.
108. Zhou Z., Deng H., Yan W., Huang H., Deng Y., Li Y., et al. Expression of metadherin/AEG-1 gene is positively related to orientation chemotaxis and adhesion of human hepatocellular carcinoma cell lines of different metastatic potentials. Journal of Huazhong University of Science and Technology. Medical Sciences 2012, 32(3):353-357.
109. Zhou J., Li J., Wang Z., Yin C., Zhang W. Metadherin is a novel prognostic marker for bladder cancer progression and overall patient survival. Asia-Pacific Journal of Clinical Oncology 2012, 8(3):e42-e48.
110. Zhu K., Dai Z., Pan Q., Wang Z., Yang G.H., Yu L., et al. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research 2011, 17(23):7294-7302.